Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors [Phase 2]
Phase 2 monotherapy trial of tovorafenib (DAY101) in melanoma and other solid tumors was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis [Phase 1, Phase 2]
Completed Phase 1/2 study evaluating cryotherapy with in situ immunotherapy for metastatic melanoma (skin).
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: 18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma [NA]
A completed clinical trial evaluating 18F-FDG PET imaging to identify tumor exhaustion early to guide immunotherapy in patients with locally…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Taxoprexin Treatment for Advanced Skin Melanoma [Phase 2]
A Phase 2 trial update reports completion of testing Taxoprexin in patients with advanced/metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients [Phase 1]
Phase 1b trial evaluates safety of MB097 in combination with pembrolizumab for melanoma; study is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma [Phase 2]
Phase 2 clinical trial update (LUMINOS-102) evaluating lerapolturev with or without immune checkpoint blockade in advanced PD-1 refractory m…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Zr89 + PET Companion Trial [EARLY_Phase 1]
An early-phase 1 trial evaluating Zirconium-89 as a PET imaging companion for melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma [Phase 1]
Phase 1 study evaluating LBL-007 in combination with toripalimab and axitinib in advanced melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors [Phase 1]
Pfizer's PF-07820435 study in advanced solid tumors, including non-small-cell lung cancer and other indications, has been terminated at Phas…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma [NA]
This clinical trial update reports a completed study evaluating immunomonitoring for nivolumab with or without ipilimumab in metastatic mela…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Dendritic Cell Activating Scaffold in Melanoma [Phase 1]
A Phase 1 clinical trial evaluating a Dendritic Cell Activating Scaffold in patients with melanoma has completed the study.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies [Phase 4]
Phase 4 trial update on anti-PD1 monoclonal antibodies for metastatic melanoma indicates the study has completed (status: COMPLETED). No eff…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer [Phase 1]
Phase 1 trial update of PeptiCRAd-1 reports safety signals and anti-tumor activity across multiple cancers; trial status is ACTIVE_NOT_RECRU…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma [Phase 2, Phase 3]
A phase 2/3 trial evaluating CMP-001 in combination with nivolumab versus nivolumab monotherapy in advanced or unresectable melanoma was ter…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients [Phase 1]
Phase 1 trial assessing the PK similarity between FYB206 and pembrolizumab (Keytruda) in resected stage II/III melanoma; status is active no…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02) [Phase 1, Phase 2]
This clinical trial update reports the safety and efficacy of pembrolizumab in combination with investigational agents for PD-1 refractory m…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593) [Phase 4]
This Phase 4 trial evaluated the safety of pembrolizumab in patients with unresectable or metastatic melanoma or non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies [Phase 1]
The Phase 1 study evaluating AB308 in combination with AB122 in participants with advanced malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: TRAQinform Assessment of Immunotherapy Response
A completed clinical trial evaluating TRAQinform, an assessment tool for immunotherapy response in melanoma. The study is sponsored by AIQ S…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma [Phase 2]
Phase 2 clinical trial update assessing tolerability and potential clinical benefit of fecal microbiota transplantation in patients with mel…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy
Clinical trial update reporting immune responses in prostate, lung, melanoma, and breast cancer patients after SBRT, IMRT, or brachytherapy.
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1). [Phase 1, Phase 2]
The OMNIA-1 study evaluated ANV419 alone or with approved treatment in melanoma (including cutaneous/metastatic disease) in Phase 1/2; the t…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma [Phase 1, Phase 2]
This update reports the termination of a phase 1/2 trial evaluating cabozantinib in combination with pembrolizumab for advanced metastatic m…
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma [Phase 3]
Phase 3 clinical trial update evaluating a subcutaneous fixed-dose combination of nivolumab and relatlimab in previously untreated metastati…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) [Phase 1, Phase 2]
Phase 1/2 trial results for GLIMMER-01, a bi-sialidase fusion protein from Palleon, tested across multiple solid tumors with results posted …